Atara Biotherap Cmn (ATRA) Ownership Up in Latest Report from Arrowpoint Asset Management, LLC

0
107

Atara Biotherap Cmn (NASDAQ:ATRA).

Arrowpoint Asset Management, LLC says it raised its investment in Atara Biotherap Cmn stock by 692,704 shares in the quarter ending 09/30/2017. Its stake was worth $45,938,000 an increase of $16,776,000 according to the filing.

These firms have modified their investment in ATRA. As of quarter end Alyeska Investment Group, L.p. had acquired a total of 3,123 shares growing its position 1.8%. The value of the investment in Atara Biotherap Cmn went from $2,404,000 to $2,894,000 a change of $490,000 quarter to quarter. As of the end of the quarter Geode Capital Management, LLC had bought 3,685 shares growing its stake by 2.0%. The value of the company’s investment in Atara Biotherap Cmn increased from $2,637,000 to $3,179,000 increasing 20.6% since the last quarter.

As of quarter end Neuberger Berman Group LLC had acquired a total of 147,061 shares growing its holdings by 15.2%. The value of the investment in ATRA went from $13,552,000 to $18,454,000 a change of 36.2% for the reporting period.

November 9 investment analysts at Canaccord Genuity kept a “Buy” rating on the company. October 6 investment analysts at Goldman Sachs Group, Inc. (The) made no change to the stock rating of “Neutral” projecting a price of $20.00.

On October 5 Jefferies Group LLC maintained a stock rating of “Buy” targeting a price of $30.00. September 11 investment analysts at Canaccord Genuity maintained a company rating of “Buy” with a current price target of $47.00.

On August 31 Jefferies Group LLC left the company rating at “Buy” targeting a price of $30.00. Canaccord Genuity released a research note on ATRA with a rating of “Buy” and setting a price target of $47.00.

The company is so far trading unchanged from yesterday’s close of 14.50. The most current P/E ratio is N/A and market cap is 443.64M. As of the latest earnings report the EPS was $-3.47 with 30.60M shares now outstanding.

Investors are a little more bearish on shares of Atara Biotherap Cmn lately as inferred by the change in short interest. The firm saw a rise in short interest of 4.12% between September 29, 2017 and October 13, 2017. Short shares grew 185,149 over that timeframe. Days to cover increased 2.0 to 28.0 and the short interest percentage is 0.15% as of October 13.